Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Dow
AstraZeneca
Express Scripts
Johnson and Johnson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Vintage Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for VINTAGE PHARMS, and what generic and branded alternatives to VINTAGE PHARMS drugs are available?

VINTAGE PHARMS has one hundred and eight approved drugs.



Summary for Vintage Pharms
US Patents:0
Tradenames:70
Ingredients:56
NDAs:108

Drugs and US Patents for Vintage Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070221-005 Sep 24, 1986 AB RX No No   Start Trial   Start Trial
Vintage Pharms GRISEOFULVIN griseofulvin, microsize SUSPENSION;ORAL 065438-001 Oct 8, 2010 AB RX No No   Start Trial   Start Trial
Vintage Pharms PERPHENAZINE perphenazine TABLET;ORAL 040226-004 Dec 31, 1998 AB RX No No   Start Trial   Start Trial
Vintage Pharms PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 040507-001 Jul 30, 2003 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Harvard Business School
Express Scripts
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.